FoxO1转录因子与肝纤维化的关系研究进展
廖丹1 钱波2 徐敏1
1.南京医科大学上海市第一人民医院消化内科,上海 200080;
2.江苏省启东市妇幼保健院内科,江苏启东 226200
Advances in the relationship between FoxO1 transcription factors and liver fibrosis
LIAO Dan1 QIAN Bo2 XU Min1
1.Department of Gastroenterology, Shanghai First People′s Hospital, Nanjing Medical University, Shanghai 200080, China;
2.Department of Internal Medicine, Maternal and Child Health Hospital of Jiangsu Province, Jiangsu Province, Qidong 226200, China
摘要 FoxO1作为叉头转录因子家族中的成员,能够促进肝细胞糖异生基因的表达,同时促进ApoC-Ⅲ的表达,形成非酒精性脂肪肝病导致肝纤维化;FoxO1通过调节自噬基因的表达及参与肝星状细胞自噬来调节肝纤维化;FoxO1能通过参与肝星状细胞细胞周期阻滞而调节肝纤维化;PDGF因子可以通过调节FoxO1表达参与肝星状细胞的活化而调节肝纤维化;FoxO1通过参与脂肪细胞、肌纤维细胞的分化来调节肝纤维化的形成。本文将从上述方面阐述FoxO1与肝纤维化的关系进行综述。
关键词 :
FoxO1 ,
肝纤维化 ,
肝星状细胞 ,
糖脂代谢 ,
自噬 ,
细胞周期阻滞 ,
细胞分化
Abstract :FoxO1, as a member of the forkhead transcription factor family, can promote the expression of gluconeogenesis genes in hepatocytes, and promote the expression of ApoC-Ⅲ to form liver fibrosis caused by nonalcoholic fatty liver disease; FoxO1 regulates the expression of autophagy genes. Participate in autophagy of hepatic stellate cells to regulate liver fibrosis; FoxO1 can participate in hepatic stellate cell cycle arrest to regulate liver fibrosis; PDGF factor can regulate FoxO1 expression involved in hepatic stellate cell activation and regulate liver fibrosis; FoxO1 participates in fat differentiation of cells and myofibroblasts regulates the formation of liver fibrosis. This article will review the relationship between FoxO1 and liver fibrosis in the above aspects.
Key words :
FoxO1
Liver fibrosis
Hepatic stellate cells
Glycolipid metabolism
Autophagy
Cell cycle arrest
Cell differentiation
基金资助: 上海市科学技术委员会科研计划项目(18YF14 20000)。
通讯作者:
徐敏(1973.2-),女,博士,南京医科大学及上海交通大学硕士生导师,上海市第一人民医院消化内科主任,主要从事消化道早癌,急性胰腺炎等疾病的研究。
作者简介 : 廖丹(1992.8-),女,南京医科大学上海市第一人民医院2016级消化专业在读硕士研究生,主要从事消化系统疾病,胰腺炎等方面的研究。
[1] 胡潇,胡光荣,刘思达,等.肝纤维化治疗进展[J].肝脏,2018,23(10):931-933.
[2] 周骅,曹新生,胡泽兵,等.FOXOs转录因子生物学功能的研究进展[J].现代生物医学进展,2017,17(1):185-188.
[3] Ray,K. Liver:Hepatic stellate cells hold the key to liver fibrosis [J]. Nat Rev Gastroenterol Hepatol,2014,11(2):74.
[4] Ayd?覦n MM,Ak?觭al?覦 KC. Liver fibrosis [J]. Turk J Gastroenterol,2018,29(1):14-21.
[5] Troeger JS,Mederacke L,Gwak GY,et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice [J]. Gastroenterology,2012,143(4):1073-1083.
[6] Weigel D,Jurgens G,Kuttner F,et al. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo [J]. Cell,1989,57(4):645-658
[7] 陈小玲,黄志清,毛湘冰,等.FoxO1的功能研究进展[J].中国畜牧兽医,2011,38(9):90-93.
[8] Luo CT,Liao W,Dadi S,et al. Graded Foxo1 activity in T-reg cells differentiates tumour immunity from spontaneous autoimmunity [J]. Nature,2016,529(7587):532-536.
[9] Younossi M,Koenig AB,Abdelatif D,et al. Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence,Incidence,and Outcomes [J]. Hepatology,2016,64(1):73-84.
[10] 冯巩,贺娜,王菊宁,等.非酒精性脂肪性肝病的流行病学与血清无创诊断研究进展[J].中华肝脏病杂志,2018, 26(6):476-480.
[11] 赵航,张运佳,树林一,等.FoxO1在肝脏糖脂代谢中的作用[J].基础医学与临床,2019,39(1):115-119.
[12] Mallat A,Lodder J,Teixeira-Clerc F,et al. Autophagy:A Multifaceted Partner in Liver Fibrosis [J]. Biomed Res Int,2014:869390.
[13] 郭静,赵钦花,王玉芹,等.FoxO1和自噬相关基因Beclin1在PCOS患者子宫内膜中的表达水平及意义[J].热带医学杂志,2018,18(12):1557-1561.
[14] 张悦,管叙文,王婧雅,等.miR-27a对胃癌细胞凋亡影响的体外研究[J].天津医科大学学报,2018,24(6):469-473.
[15] 徐俊,黄秀兰.SIRT1-FoxO-自噬通路研究进展[J].中国药理学通报,2014,(7):901-904.
[16] Lodder J,Dena?觕s T,Chobert MN,et al. Macrophage autophagy protects against liver fibrosis in mice [J]. Autophagy,2015,11(8):1280-1292.
[17] Guimaraes EL,Najimi M,van Grunsven LA,et al. A role for autophagy during hepatic stellate cell activation [J]. J Hepatol,2011,55(6):1353-1360.
[18] Tia N,Singh AK,Pandey P,et al. Role of Forkhead Box O(FOXO)transcription factor in aging and diseases [J]. Gene,2018,648:97-105.
[19] Adachi M,Osawa Y,Uchinami H,et al. The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells [J]. Gastroenterology,2007,132(4):1434-1446.
[20] 张扬,吴朝蒙,雷博涵,等.PI3K/AKT/FOXO1信号通路参与复方中药CFF-1诱导的前列腺癌细胞凋亡和周期阻滞[J].中华男科学杂志,2017,23(9):828-837.
[21] Zhang XD,Hu H,Chen J,et al. Berberine Inhibits Hepatic Stellate Cell Proliferation and Prevents Experimental Liver Fibrosis [J]. Biol Pharm Bull,2009,32(9):1533-1537.
[22] 张玉洁,洪汝涛,揭磊.褪黑素对PDGF-BB诱导的HSC-T6细胞增殖的影响及机制[J].安徽医科大学学报,2018,53(12):1828-1833.
[23] 倪达,薛松,连锋,等.PDGF通过AKT/FoxO信号通路促进血管平滑肌细胞增殖[J].中国分子心脏病学杂志,2011,11(6):346-349.
[24] Jing F,Geng Y,Xu XY,et al. MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H? Transporting V1 Subunit C1 [J]. Int J Mol Sci,2019,20(4):E796.
[25] Gupta G,Khadem F,Uzonna JE. T Role of hepatic stellate cell(HSC)-derived cytokines in hepatic inflammation and immunity [J]. Cytokine,2018,18:30371-30375.
[26] Chang WJ,Song LJ,Yi T,et al. Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury [J]. World J Gastroenterol,2015,21(14):4184-4194.
[27] 邹磊,王玉华,蔡春友,等.PCAF通过调控FOXO1活性参与3T3-L1前脂肪细胞分化[J].天津医科大学学报,2015(3):203-207.
[28] Vincent KJ,Jones E,Arthur MJ,et al. Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells [J]. Gut,2001,49(5):713-719.
[29] Yin C,Evason KJ,Asahina K,et al. Hepatic stellate cells in liver development,regeneration,and cancer [J]. J Clin Invest,2013,123(5):1902-1910.
[1]
师小径 郑明奋 万仁强 张沈华. 紫杉醇对人鼻咽癌细胞体外自噬的影响 [J]. 中国医药导报, 2019, 16(9): 22-25.
[2]
靳雯臻1 谭晓川1 文瑾2 宋辉1 张宇佳1 郑稳生1. 靶向肝星状细胞治疗肝纤维化的纳米递送系统研究进展 [J]. 中国医药导报, 2019, 16(9): 34-37.
[3]
李章勇1 林应标1▲ 夏川1 李刚勇2. 肝纤维化指标联合AFP、GGT检测在肝病诊断中的应用价值 [J]. 中国医药导报, 2019, 16(7): 153-156.
[4]
林晓莹1 黄浩峰1 陈浩2 李树朋3 赵斌4 钟望涛5 冯杜1. MFN2调控线粒体动态变化的研究进展 [J]. 中国医药导报, 2019, 16(13): 42-45.
[5]
李晓永1 张国顺2. 扶正化瘀胶囊联合异甘草酸镁治疗失代偿期肝硬化患者的临床效果 [J]. 中国医药导报, 2019, 16(11): 138-141.
[6]
白洁1 纪文静1 丁永年1 彭媛媛1 努尔麦麦提·叶尔逊1 阿孜古力·阿不来提1 陈源文2. miRNA-101调控转化生长因子-β1信号通路参与肝纤维化的研究 [J]. 中国医药导报, 2019, 16(1): 16-19,23.
[7]
田宇 毛於安▲. 慢传输型便秘大鼠结肠Cajal间质细胞自噬现象的发生及钙离子水平的定性分析 [J]. 中国医药导报, 2018, 15(8): 20-23.
[8]
郑婷 杨定平▲. 脓毒症急性肾损伤的研究机制及进展 [J]. 中国医药导报, 2018, 15(6): 24-27.
[9]
方慧 刘琪. 牙周炎与活性氧致病机制的研究进展 [J]. 中国医药导报, 2018, 15(5): 22-26.
[10]
张浩然1 乔旭旭1 毕明宏1 翟云芝1 钱立宇2 潘成武2 赵论1. DEPTOR-mTOR信号通路介导的自噬在多发性骨髓瘤中对破骨细胞分化的调控作用 [J]. 中国医药导报, 2018, 15(4): 18-22.
[11]
林彤 沙永强 陈泽雄. 中药活性成分诱导肝细胞癌自噬的体外实验研究进展 [J]. 中国医药导报, 2018, 15(34): 49-52,56.
[12]
王佳贺 王超. 细胞自噬对岩大戟内酯B诱导的白血病细胞HL-60凋亡的影响 [J]. 中国医药导报, 2018, 15(28): 13-16细胞自噬对岩大戟内酯B诱导的.
[13]
张浩然 乔旭旭 毕明宏. 哺乳动物雷帕霉素靶蛋白介导细胞自噬在肿瘤中的研究进展 [J]. 中国医药导报, 2018, 15(25): 32-35.
[14]
徐赵钕 章仕淼 刘玲玲. 明目地黄丸对糖尿病视网膜病变大鼠细胞自噬及Akt-mTOR通路的影响 [J]. 中国医药导报, 2018, 15(20): 16-20,32.
[15]
许继文1 李金霞2 张华敏3▲. 中医药调控心血管疾病自噬研究进展 [J]. 中国医药导报, 2018, 15(10): 38-41.